Celestica's Q4 AI Surge Meets Sobering Valuation Reality

What happened

Celestica reported exceptional Q4 2025 results, with revenue up 44% year-over-year to $3.65 billion and EPS surging 70% to $1.89, driven by hyperscaler demand for 800G networking and AI compute deployments. Full-year EPS grew 98%, showcasing strong operating leverage and cost absorption, as highlighted in the Seeking Alpha article. Management's 2026 outlook projects $17 billion in revenue (+37%) and $8.75 EPS (~45% growth), with Connectivity & Cloud Solutions (CCS) as the primary driver, indicating continued momentum in AI infrastructure. However, the DeepValue report underscores that at a share price of $313.60, Celestica trades at lofty multiples—52x 2024 P/E and 50x EV/EBITDA—with a base case intrinsic value of only $260, reflecting embedded risks from customer concentration and shallow moats. Despite the near-term strength, the stock's valuation already discounts much of this aggressive growth, leaving investors exposed to significant downside if hyperscaler capex moderates or execution falters.

Implication

Celestica's Q4 beat and raised 2026 guidance confirm its role as a premier AI infrastructure play, likely sustaining short-term momentum and bullish sentiment. However, the stock's premium valuation offers limited upside, with the base case implying potential downside to $260, while bear scenarios suggest a drop to $190 if margins compress or growth slows. Critical risks include heavy reliance on a few hyperscalers without contractual minimums, rising competition from peers like Flex and Arista, and the cyclical nature of AI capex, which could abruptly reset earnings. Any misstep in 800G/1.6T ramps or a hyperscaler capex slowdown could trigger simultaneous earnings and multiple compression, eroding shareholder value rapidly. Disciplined investors should consider trimming positions or waiting for a pullback below $240, as per the DeepValue report, to mitigate downside while monitoring for durable post-2026 economics.

Thesis delta

The new Q4 results and 2026 outlook do not shift the core DeepValue thesis, which already anticipated strong near-term growth but warned of overvaluation and concentration risks. If anything, the confirmation of aggressive targets reinforces the caution, as the stock price likely embeds this optimism, increasing vulnerability to future disappointments. No material change is warranted; investors should maintain a critical stance, focusing on risk management rather than chasing momentum.